525 related articles for article (PubMed ID: 25043018)
1. Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles.
Walz S; Lorenzin F; Morton J; Wiese KE; von Eyss B; Herold S; Rycak L; Dumay-Odelot H; Karim S; Bartkuhn M; Roels F; Wüstefeld T; Fischer M; Teichmann M; Zender L; Wei CL; Sansom O; Wolf E; Eilers M
Nature; 2014 Jul; 511(7510):483-7. PubMed ID: 25043018
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of RNA polymerase II and transcriptional dynamics upon MYC activation.
de Pretis S; Kress TR; Morelli MJ; Sabò A; Locarno C; Verrecchia A; Doni M; Campaner S; Amati B; Pelizzola M
Genome Res; 2017 Oct; 27(10):1658-1664. PubMed ID: 28904013
[TBL] [Abstract][Full Text] [Related]
3. Myc interacts with Max and Miz1 to repress C/EBPdelta promoter activity and gene expression.
Si J; Yu X; Zhang Y; DeWille JW
Mol Cancer; 2010 Apr; 9():92. PubMed ID: 20426839
[TBL] [Abstract][Full Text] [Related]
4. Myc regulates keratinocyte adhesion and differentiation via complex formation with Miz1.
Gebhardt A; Frye M; Herold S; Benitah SA; Braun K; Samans B; Watt FM; Elsässer HP; Eilers M
J Cell Biol; 2006 Jan; 172(1):139-49. PubMed ID: 16391002
[TBL] [Abstract][Full Text] [Related]
5. Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15.
Inoue S; Hao Z; Elia AJ; Cescon D; Zhou L; Silvester J; Snow B; Harris IS; Sasaki M; Li WY; Itsumi M; Yamamoto K; Ueda T; Dominguez-Brauer C; Gorrini C; Chio II; Haight J; You-Ten A; McCracken S; Wakeham A; Ghazarian D; Penn LJ; Melino G; Mak TW
Genes Dev; 2013 May; 27(10):1101-14. PubMed ID: 23699408
[TBL] [Abstract][Full Text] [Related]
6. Gene regulation: fine-tuned amplification in cells.
Dang CV
Nature; 2014 Jul; 511(7510):417-8. PubMed ID: 25043013
[No Abstract] [Full Text] [Related]
7. The Interaction of Myc with Miz1 Defines Medulloblastoma Subgroup Identity.
Vo BT; Wolf E; Kawauchi D; Gebhardt A; Rehg JE; Finkelstein D; Walz S; Murphy BL; Youn YH; Han YG; Eilers M; Roussel MF
Cancer Cell; 2016 Jan; 29(1):5-16. PubMed ID: 26766587
[TBL] [Abstract][Full Text] [Related]
8. c-Myc activates BRCA1 gene expression through distal promoter elements in breast cancer cells.
Chen Y; Xu J; Borowicz S; Collins C; Huo D; Olopade OI
BMC Cancer; 2011 Jun; 11():246. PubMed ID: 21668996
[TBL] [Abstract][Full Text] [Related]
9. Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis.
Sabò A; Kress TR; Pelizzola M; de Pretis S; Gorski MM; Tesi A; Morelli MJ; Bora P; Doni M; Verrecchia A; Tonelli C; Fagà G; Bianchi V; Ronchi A; Low D; Müller H; Guccione E; Campaner S; Amati B
Nature; 2014 Jul; 511(7510):488-492. PubMed ID: 25043028
[TBL] [Abstract][Full Text] [Related]
10. HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity.
Gordan JD; Bertout JA; Hu CJ; Diehl JA; Simon MC
Cancer Cell; 2007 Apr; 11(4):335-47. PubMed ID: 17418410
[TBL] [Abstract][Full Text] [Related]
11. Inhibiting MYC binding to the E-box DNA motif by ME47 decreases tumour xenograft growth.
Lustig LC; Dingar D; Tu WB; Lourenco C; Kalkat M; Inamoto I; Ponzielli R; Chan WCW; Shin JA; Penn LZ
Oncogene; 2017 Dec; 36(49):6830-6837. PubMed ID: 28806396
[TBL] [Abstract][Full Text] [Related]
12. The interaction between Myc and Miz1 is required to antagonize TGFbeta-dependent autocrine signaling during lymphoma formation and maintenance.
van Riggelen J; Müller J; Otto T; Beuger V; Yetil A; Choi PS; Kosan C; Möröy T; Felsher DW; Eilers M
Genes Dev; 2010 Jun; 24(12):1281-94. PubMed ID: 20551174
[TBL] [Abstract][Full Text] [Related]
13. In vivo transcriptional regulation of N-Myc target genes is controlled by E-box methylation.
Perini G; Diolaiti D; Porro A; Della Valle G
Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12117-22. PubMed ID: 16093321
[TBL] [Abstract][Full Text] [Related]
14. MXD/MIZ1 transcription regulatory complexes activate the expression of MYC-repressed genes.
Shostak A; Schermann G; Diernfellner A; Brunner M
FEBS Lett; 2021 Jun; 595(12):1639-1655. PubMed ID: 33914337
[TBL] [Abstract][Full Text] [Related]
15. Compensatory RNA polymerase 2 loading determines the efficacy and transcriptional selectivity of JQ1 in Myc-driven tumors.
Donato E; Croci O; Sabò A; Muller H; Morelli MJ; Pelizzola M; Campaner S
Leukemia; 2017 Feb; 31(2):479-490. PubMed ID: 27443262
[TBL] [Abstract][Full Text] [Related]
16. An early Myc-dependent transcriptional program orchestrates cell growth during B-cell activation.
Tesi A; de Pretis S; Furlan M; Filipuzzi M; Morelli MJ; Andronache A; Doni M; Verrecchia A; Pelizzola M; Amati B; Sabò A
EMBO Rep; 2019 Sep; 20(9):e47987. PubMed ID: 31334602
[TBL] [Abstract][Full Text] [Related]
17. DLX5 (distal-less homeobox 5) promotes tumor cell proliferation by transcriptionally regulating MYC.
Xu J; Testa JR
J Biol Chem; 2009 Jul; 284(31):20593-601. PubMed ID: 19497851
[TBL] [Abstract][Full Text] [Related]
18. TSA suppresses miR-106b-93-25 cluster expression through downregulation of MYC and inhibits proliferation and induces apoptosis in human EMC.
Zhao ZN; Bai JX; Zhou Q; Yan B; Qin WW; Jia LT; Meng YL; Jin BQ; Yao LB; Wang T; Yang AG
PLoS One; 2012; 7(9):e45133. PubMed ID: 23028803
[TBL] [Abstract][Full Text] [Related]
19. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
20. OmoMYC blunts promoter invasion by oncogenic MYC to inhibit gene expression characteristic of MYC-dependent tumors.
Jung LA; Gebhardt A; Koelmel W; Ade CP; Walz S; Kuper J; von Eyss B; Letschert S; Redel C; d'Artista L; Biankin A; Zender L; Sauer M; Wolf E; Evan G; Kisker C; Eilers M
Oncogene; 2017 Apr; 36(14):1911-1924. PubMed ID: 27748763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
